Latest Articles

Zacks.com

Pipeline Advances at Isis Pharma - Analyst Blog

Isis Pharmaceuticals, Inc. ( ISIS ) recently announced that it has initiated a phase II study (n = 20) to evaluate the safety and efficacy of its paroxysmal atrial fibrillation (AF) candidate, ISIS-CRP. The randomized, placebo-controlled, multiple-dose, phase II study will evaluate the use of ISIS-CRP,... Read >>

Schaeffer's Investment Research

The Dow Challenges Record High Before Pre-Sequester Sell-Off

"After four straight 100-plus-point moves in the Dow, it was nice to have a catch-your-breath type of day" said Schaeffer's Senior Technical Strategist Ryan Detrick, CMT, as the Dow Jones Industrial Average closed with modest losses after notching yet another multi-year peak. "With the series of... Read >>

Zacks.com

FPMI: CardioPET Excellent Image Quality from Phase II - Analyst Blog

FPMI: CardioPET Excellent Image Quality from Phase II By Brian Marckx, CFA This morning (2/28/2013) FluoroPharma (OTC BB: FPMI ) announced that the initial images from phase II trials of their CardioPET imaging agent candidate "show high resolution in the heart and provides extremely clear... Read >>

Zacks.com

St. Jude Beefs Up Dividend - Analyst Blog

Medical technology major, St. Jude Medical Inc. ( STJ ) has hiked its quarterly dividend by 9% to 25 cents a share from 23 cents. This lifts the annual dividend to $1.00 per share from the current payout of 92 cents and equates to a dividend yield of roughly 2.4%. The revised quarterly dividend is payable... Read >>

NASDAQ.com News

Pre-Market Earnings Report for March 1, 2013 : MGA, POM, DRC, HPT, FWLT, EVEP, XLS, PNM, PGH, XTEX, NWN, EXLS

The following companies are expected to report earnings prior to market open on 03/01/2013. Visit our Earnings Calendar for a full list of expected earnings releases. Magna International, Inc. ( MGA ) is reporting for the quarter ending December 31, 2012. The auto (truck) company's consensus earnings per... Read >>

Zacks.com

Priority Review for Bayer's Drug - Analyst Blog

Bayer 's ( BAYRY ) Healthcare unit recently announced that its oncology candidate regorafenib, was granted priority review by the Japanese Ministry of Health, Labour and Welfare (MHLW) for the treatment of patients suffering from unresectable and/or metastatic gastrointestinal stromal tumors (GIST). In... Read >>

Zacks.com

JetBlue in Deal with Airbus - Analyst Blog

JetBlue Airways ( JBLU ) has agreed to purchase 110 ship-sets of retrofit Sharklets from leading aircraft manufacturer - Airbus. Per the letter of intent signed between the two companies, the Sharklets will be utilized for the carrier's A320 aircraft that are in service. Although none of the... Read >>

Renaissance Capital

UK-based shuttle tanker operator KNOT Offshore Partners files for US IPO

KNOT Offshore Partners LP, a recently formed LP which will own, operate and acquire shuttle tankers under long-term charters, filed on Thursday with the SEC to raise up to $100 million in an initial public offering. The Aberdeen, United Kingdom-based company, which was founded in 2013 and booked $66 million... Read >>

Zacks.com

5 Solid ETF Investment Picks for Retirement - ETF News And Commentary

This article was written by Brian Spero, a regular contributor for the financial resource, Money Crashers , where he shares his tips for investing and smart money management. Exchange-traded funds (ETFs) have often been ignored when it comes to investing for retirement, but the latest trends suggest a... Read >>

David Moenning

State of the Market: Today's Most Compelling Buy (Feb. 28, 2013)

State of the Market:  Today's Most Compelling Buy Thursday, February 28, 2013 At StatoftheMarkets.com , we strive to "own the best and ignore the rest" in our equity portfolios. Toward this end, each day we search our database for a "top stock" (a top rated company in terms of earnings... Read >>